Carmustine and Colitis - a phase IV clinical study of FDA data

Summary:

Colitis is reported as a side effect among people who take Carmustine (carmustine), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Melphalan, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Colitis when taking Carmustine. It is created by eHealthMe based on reports of 4,562 people who have side effects when taking Carmustine from the FDA, and is updated regularly.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

What is Colitis?

Colitis (inflammation of colon) is found to be associated with 1,651 drugs and 1,519 conditions by eHealthMe. Check the latest studies of Colitis.

On Nov, 18, 2025

4,562 people reported to have side effects when taking Carmustine.
Among them, 48 people (1.05%) have Colitis.

Among these 48 people:

How long have people been on Carmustine when they have Colitis? *

What is the gender of people who have Colitis when taking Carmustine? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Colitis when taking Carmustine? *

What are other drugs people take besides Carmustine? *

What are other side effects people have besides Colitis? *

Pneumonia: 14 people, 29.17%
Mucosal Inflammation (infection of mucous membrane): 13 people, 27.08%
Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 11 people, 22.92%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 10 people, 20.83%
Liver Injury: 10 people, 20.83%
Diarrhea: 8 people, 16.67%
Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 7 people, 14.58%
Anosognosia (ignorance of the presence of disease): 7 people, 14.58%
Hemianopia (blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain): 7 people, 14.58%
Weakness: 7 people, 14.58%

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 13 people, 27.08%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 16.67%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 7 people, 14.58%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 4 people, 8.33%
Burkitt Lymphoma (cancer of the lymphatic system): 4 people, 8.33%
Rashes (redness): 3 people, 6.25%
Nausea (feeling of having an urge to vomit): 3 people, 6.25%
Lymphoma (cancer that begins in immune system cells): 2 people, 4.17%
Haematopoietic Stem Cell Mobilisation: 2 people, 4.17%
Febrile Neutropenia (fever with reduced white blood cells): 2 people, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Carmustine and have Colitis?

- Check whether Colitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carmustine:

Carmustine (4,562 reports)

Colitis treatments and more:

Colitis (53,787 reports)

Browse all side effects of Carmustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Colitis:

Colitis (1,651 drugs)

Browse all the conditions that are associated with Colitis:

Colitis (1,519 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carmustine (the active ingredients of Carmustine) and Carmustine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.